BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Laufs A, Livingstone R, Nowotny B, Nowotny P, Wickrath F, Giani G, Bunke J, Roden M, Hwang J. Quantitative liver 31 P magnetic resonance spectroscopy at 3T on a clinical scanner: Quantitative Liver 31 P MR Spectroscopy on a 3T Clinical Scanner. Magn Reson Med 2014;71:1670-5. [DOI: 10.1002/mrm.24835] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Sedivy P, Dusilova T, Hajek M, Burian M, Krššák M, Dezortova M. In Vitro 31P MR Chemical Shifts of In Vivo-Detectable Metabolites at 3T as a Basis Set for a Pilot Evaluation of Skeletal Muscle and Liver 31P Spectra with LCModel Software. Molecules 2021;26:7571. [PMID: 34946652 DOI: 10.3390/molecules26247571] [Reference Citation Analysis]
2 Jones JG. Non-Invasive Analysis of Human Liver Metabolism by Magnetic Resonance Spectroscopy. Metabolites 2021;11:751. [PMID: 34822409 DOI: 10.3390/metabo11110751] [Reference Citation Analysis]
3 Pesta D, Jelenik T, Zaharia OP, Bobrov P, Görgens S, Bódis K, Karusheva Y, Krako Jakovljevic N, Lalic NM, Markgraf DF, Burkart V, Müssig K, Knebel B, Kotzka J, Eckel J, Strassburger K, Szendroedi J, Roden M. NDUFB6 Polymorphism Is Associated With Physical Activity-Mediated Metabolic Changes in Type 2 Diabetes. Front Endocrinol (Lausanne) 2021;12:693683. [PMID: 34659107 DOI: 10.3389/fendo.2021.693683] [Reference Citation Analysis]
4 Zaharia OP, Kupriyanova Y, Karusheva Y, Markgraf DF, Kantartzis K, Birkenfeld AL, Trenell M, Sahasranaman A, Cheyette C, Kössler T, Bódis K, Burkart V, Hwang JH, Roden M, Szendroedi J, Pesta DH. Improving insulin sensitivity, liver steatosis and fibrosis in type 2 diabetes by a food-based digital education-assisted lifestyle intervention program: a feasibility study. Eur J Nutr 2021. [PMID: 33839905 DOI: 10.1007/s00394-021-02521-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kupriyanova Y, Zaharia OP, Bobrov P, Karusheva Y, Burkart V, Szendroedi J, Hwang JH, Roden M; GDS group. Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus. J Hepatol 2021;74:1028-37. [PMID: 33259845 DOI: 10.1016/j.jhep.2020.11.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Rothe M, Wessel C, Cames S, Szendroedi J, Burkart V, Hwang JH, Roden M. In vivo absolute quantification of hepatic γ-ATP concentration in mice using 31 P MRS at 11.7 T. NMR Biomed 2021;34:e4422. [PMID: 33025629 DOI: 10.1002/nbm.4422] [Reference Citation Analysis]
7 Gancheva S, Caspari D, Bierwagen A, Jelenik T, Caprio S, Santoro N, Rothe M, Markgraf DF, Herebian D, Hwang JH, Öner-Sieben S, Mennenga J, Pacini G, Thimm E, Schlune A, Meissner T, Vom Dahl S, Klee D, Mayatepek E, Roden M, Ensenauer R. Cardiometabolic risk factor clustering in patients with deficient branched-chain amino acid catabolism: A case-control study. J Inherit Metab Dis 2020;43:981-93. [PMID: 32118306 DOI: 10.1002/jimd.12231] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Rivera D, Kalleveen I, de Castro CA, van Laarhoven H, Klomp D, van der Kemp W, Stoker J, Nederveen A. Inherently decoupled 1 H antennas and 31 P loops for metabolic imaging of liver metastasis at 7 T. NMR Biomed 2020;33:e4221. [PMID: 31922319 DOI: 10.1002/nbm.4221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zaharia OP, Strassburger K, Strom A, Bönhof GJ, Karusheva Y, Antoniou S, Bódis K, Markgraf DF, Burkart V, Müssig K, Hwang JH, Asplund O, Groop L, Ahlqvist E, Seissler J, Nawroth P, Kopf S, Schmid SM, Stumvoll M, Pfeiffer AFH, Kabisch S, Tselmin S, Häring HU, Ziegler D, Kuss O, Szendroedi J, Roden M; German Diabetes Study Group. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol 2019;7:684-94. [PMID: 31345776 DOI: 10.1016/S2213-8587(19)30187-1] [Cited by in Crossref: 203] [Cited by in F6Publishing: 99] [Article Influence: 67.7] [Reference Citation Analysis]
10 Purvis LAB, Valkovič L, Robson MD, Rodgers CT. Feasibility of absolute quantification for 31 P MRS at 7 T. Magn Reson Med 2019;82:49-61. [PMID: 30892732 DOI: 10.1002/mrm.27729] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 Lev-cohain N, Sapir G, Harris T, Azar A, Gamliel A, Nardi-schreiber A, Uppala S, Sosna J, Gomori JM, Katz-brull R. Real-time ALT and LDH activities determined in viable precision-cut mouse liver slices using hyperpolarized [1- 13 C]pyruvate-Implications for studies on biopsied liver tissues. NMR in Biomedicine 2019;32:e4043. [DOI: 10.1002/nbm.4043] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
12 Pfleger L, Gajdošík M, Wolf P, Smajis S, Fellinger P, Kuehne A, Krumpolec P, Trattnig S, Winhofer Y, Krebs M, Krššák M, Chmelík M. Absolute Quantification of Phosphor-Containing Metabolites in the Liver Using 31 P MRSI and Hepatic Lipid Volume Correction at 7T Suggests No Dependence on Body Mass Index or Age. J Magn Reson Imaging 2019;49:597-607. [PMID: 30291654 DOI: 10.1002/jmri.26225] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
13 Backens M. [Technique of proton and phosphorous MR spectroscopy]. Radiologe 2017;57:428-37. [PMID: 28331946 DOI: 10.1007/s00117-017-0240-0] [Reference Citation Analysis]
14 Kahl S, Nowotny B, Strassburger K, Bierwagen A, Klüppelholz B, Hoffmann B, Giani G, Nowotny PJ, Wallscheid F, Hatziagelaki E, Pacini G, Hwang J, Roden M. Amino Acid and Fatty Acid Levels Affect Hepatic Phosphorus Metabolite Content in Metabolically Healthy Humans. The Journal of Clinical Endocrinology & Metabolism 2018;103:460-8. [DOI: 10.1210/jc.2017-01773] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
15 Gancheva S, Bierwagen A, Markgraf DF, Bönhof GJ, Murphy KG, Hatziagelaki E, Lundbom J, Ziegler D, Roden M. Constant hepatic ATP concentrations during prolonged fasting and absence of effects of Cerbomed Nemos® on parasympathetic tone and hepatic energy metabolism. Mol Metab 2018;7:71-9. [PMID: 29122559 DOI: 10.1016/j.molmet.2017.10.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Purvis LAB, Clarke WT, Valkovič L, Levick C, Pavlides M, Barnes E, Cobbold JF, Robson MD, Rodgers CT. Phosphodiester content measured in human liver by in vivo 31 P MR spectroscopy at 7 tesla. Magn Reson Med 2017;78:2095-105. [PMID: 28244131 DOI: 10.1002/mrm.26635] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
17 Valkovič L, Chmelík M, Krššák M. In-vivo31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism. Anal Biochem 2017;529:193-215. [PMID: 28119063 DOI: 10.1016/j.ab.2017.01.018] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
18 Wang D, Li YH, Fu J, Wang H. Diffusion kurtosis imaging study on temporal lobe after nasopharyngeal carcinoma radiotherapy. Brain Res 2016;1648:387-93. [PMID: 27514570 DOI: 10.1016/j.brainres.2016.07.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
19 Szendroedi J, Saxena A, Weber KS, Strassburger K, Herder C, Burkart V, Nowotny B, Icks A, Kuss O, Ziegler D, Al-Hasani H, Müssig K, Roden M; GDS Group. Cohort profile: the German Diabetes Study (GDS). Cardiovasc Diabetol 2016;15:59. [PMID: 27053136 DOI: 10.1186/s12933-016-0374-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 9.5] [Reference Citation Analysis]
20 Bashir A, Gropler R, Ackerman J. Absolute Quantification of Human Liver Phosphorus-Containing Metabolites In Vivo Using an Inhomogeneous Spoiling Magnetic Field Gradient. PLoS One 2015;10:e0143239. [PMID: 26633549 DOI: 10.1371/journal.pone.0143239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Park EY, Choi H, Yoon JY, Lee IY, Seo Y, Moon HS, Hwang JH, Jun HS. Polyphenol-Rich Fraction of Ecklonia cava Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice. Mar Drugs 2015;13:6866-83. [PMID: 26569269 DOI: 10.3390/md13116866] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
22 Runge JH, van der Kemp WJ, Klomp DW, Luijten PR, Nederveen AJ, Stoker J. 2D AMESING multi-echo (31)P-MRSI of the liver at 7T allows transverse relaxation assessment and T2-weighted averaging for improved SNR. Magn Reson Imaging 2016;34:219-26. [PMID: 26597833 DOI: 10.1016/j.mri.2015.10.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
23 Cui MH, Jayalakshmi K, Liu L, Guha C, Branch CA. In vivo (1)H MRS and (31)P MRSI of the response to cyclocreatine in transgenic mouse liver expressing creatine kinase. NMR Biomed 2015;28:1634-44. [PMID: 26451872 DOI: 10.1002/nbm.3391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Fritsch M, Koliaki C, Livingstone R, Phielix E, Bierwagen A, Meisinger M, Jelenik T, Strassburger K, Zimmermann S, Brockmann K, Wolff C, Hwang JH, Szendroedi J, Roden M. Time course of postprandial hepatic phosphorus metabolites in lean, obese, and type 2 diabetes patients. Am J Clin Nutr 2015;102:1051-8. [PMID: 26423389 DOI: 10.3945/ajcn.115.107599] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
25 Bierwagen A, Begovatz P, Nowotny P, Markgraf D, Nowotny B, Koliaki C, Giani G, Klüppelholz B, Lundbom J, Roden M. Characterization of the peak at 2.06 ppm in (31) P magnetic resonance spectroscopy of human liver: phosphoenolpyruvate or phosphatidylcholine? NMR Biomed 2015;28:898-905. [PMID: 26010913 DOI: 10.1002/nbm.3323] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
26 Hwang JH, Choi CS. Use of in vivo magnetic resonance spectroscopy for studying metabolic diseases. Exp Mol Med 2015;47:e139. [PMID: 25656949 DOI: 10.1038/emm.2014.101] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
27 Nowotny B, Zahiragic L, Bierwagen A, Kabisch S, Groener JB, Nowotny PJ, Fleitmann AK, Herder C, Pacini G, Erlund I, Landberg R, Haering HU, Pfeiffer AF, Nawroth PP, Roden M. Low-energy diets differing in fibre, red meat and coffee intake equally improve insulin sensitivity in type 2 diabetes: a randomised feasibility trial. Diabetologia 2015;58:255-64. [PMID: 25425219 DOI: 10.1007/s00125-014-3457-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
28 Hakkarainen A, Lundbom J, Tuominen EK, Taskinen MR, Pietiläinen KH, Lundbom N. Measuring short-term liver metabolism non-invasively: postprandial and post-exercise ¹H and ³¹P MR spectroscopy. MAGMA 2015;28:57-66. [PMID: 24895090 DOI: 10.1007/s10334-014-0450-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
29 Koliaki C, Roden M. Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. Mol Cell Endocrinol. 2013;379:35-42. [PMID: 23770462 DOI: 10.1016/j.mce.2013.06.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]